Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InVitae Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
InVitae Corp, Medical Devices Deals, 2012 to YTD 2018 10
InVitae Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InVitae Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
InVitae Raises USD16 Million in Venture Financing 12
InVitae Raises US$29.6 Million In Venture Financing 13
Partnerships 14
InVitae Expands Partnership with Sarepta Therapeutics 14
Invitae Enters into Agreement with Alnylam Pharma 15
Good Start Genetics Enters into Agreement with IviGen and iGenomix 16
Licensing Agreements 17
Good Start Genetics Enters into Licensing Agreement with Johns Hopkins University 17
Good Start Genetics Expands Licensing Agreement with Johns Hopkins University 18
Equity Offering 19
Invitae Prices Public Offering of Shares for USD50 Million 19
Invitae to Raise Funds through Public Offering of Shares 21
Invitae to Raise Funds through Public Offering of Shares 22
Invitae Raises USD73.5 Million in Private Placement of Shares and Preferred Shares 23
CombiMatrix Raises USD8 Million in Public Offering of Units 24
CombiMatrix Raises USD3.34 Million in Private Placement of Warrants 26
CombiMatrix Raise USD5 Million in Private Placement of Securities 28
CombiMatrix Completes Public Offering Of Units For US$12 Million 30
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million 31
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million 32
CombiMatrix Completes Private Placement Of Units For US$1.6 Million 33
Asset Transactions 34
Molecular Loop Acquires MIP-Based DNA Targeting Technology from Invitae 34
Acquisition 35
Invitae Acquires CombiMatrix for USD35 Million 35
InVitae Corp – Key Competitors 37
InVitae Corp – Key Employees 38
InVitae Corp – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Recent Developments 40
Financial Announcements 40
Aug 07, 2018: Invitae reports more than 160% annual revenue growth driven by nearly 140% annual growth in volume in second quarter 2018 40
May 09, 2018: Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018 41
Feb 12, 2018: Invitae reports over 150% volume and over 170% revenue growth for 2017 43
Jan 08, 2018: Invitae more than doubles annual volume, exceeds full-year 2017 guidance, and projects momentum to continue in 2018 45
Nov 06, 2017: Invitae Reports Double-Digit Sequential Volume and Revenue Growth in Third Quarter 2017 46
Aug 07, 2017: Invitae Reports Second Quarter 2017 Results 49
Corporate Communications 51
Sep 11, 2018: Invitae names Chitra Nayak to its Board of Directors 51
Product News 52
Dec 05, 2017: Invitae to present findings at 2017 San Antonio Breast Cancer Symposium 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53
InVitae Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InVitae Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InVitae Corp, Deals By Therapy Area, 2012 to YTD 2018 9
InVitae Corp, Medical Devices Deals, 2012 to YTD 2018 10
InVitae Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
InVitae Raises USD16 Million in Venture Financing 12
InVitae Raises US$29.6 Million In Venture Financing 13
InVitae Expands Partnership with Sarepta Therapeutics 14
Invitae Enters into Agreement with Alnylam Pharma 15
Good Start Genetics Enters into Agreement with IviGen and iGenomix 16
Good Start Genetics Enters into Licensing Agreement with Johns Hopkins University 17
Good Start Genetics Expands Licensing Agreement with Johns Hopkins University 18
Invitae Prices Public Offering of Shares for USD50 Million 19
Invitae to Raise Funds through Public Offering of Shares 21
Invitae to Raise Funds through Public Offering of Shares 22
Invitae Raises USD73.5 Million in Private Placement of Shares and Preferred Shares 23
CombiMatrix Raises USD8 Million in Public Offering of Units 24
CombiMatrix Raises USD3.34 Million in Private Placement of Warrants 26
CombiMatrix Raise USD5 Million in Private Placement of Securities 28
CombiMatrix Completes Public Offering Of Units For US$12 Million 30
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million 31
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million 32
CombiMatrix Completes Private Placement Of Units For US$1.6 Million 33
Molecular Loop Acquires MIP-Based DNA Targeting Technology from Invitae 34
Invitae Acquires CombiMatrix for USD35 Million 35
InVitae Corp, Key Competitors 37
InVitae Corp, Key Employees 38
InVitae Corp, Subsidiaries 39
List of Figures
InVitae Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
InVitae Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
InVitae Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
InVitae Corp, Medical Devices Deals, 2012 to YTD 2018 10
【免責事項】
http://www.globalresearch.jp/disclaimer